OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia
Jingnan Sun, Ruiping Hu, Mengyuan Han, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 175-181
Open Access | Times Cited: 12
Jingnan Sun, Ruiping Hu, Mengyuan Han, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 175-181
Open Access | Times Cited: 12
Showing 12 citing articles:
Advances in pyrazolo[1,5-a]pyrimidines: synthesis and their role as protein kinase inhibitors in cancer treatment
Terungwa H. Iorkula, Osasere Jude-Kelly Osayawe, Daniel A. Odogwu, et al.
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3756-3828
Open Access | Times Cited: 1
Terungwa H. Iorkula, Osasere Jude-Kelly Osayawe, Daniel A. Odogwu, et al.
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3756-3828
Open Access | Times Cited: 1
MDM2 inhibitors induce apoptosis by suppressing MDM2 and enhancing p53, Bax, Puma and Noxa expression levels in imatinib‑resistant chronic myeloid leukemia cells
Akihiro Kimura, Masanobu Tsubaki, Teruki Obana, et al.
Biomedical Reports (2025) Vol. 22, Iss. 4
Open Access | Times Cited: 1
Akihiro Kimura, Masanobu Tsubaki, Teruki Obana, et al.
Biomedical Reports (2025) Vol. 22, Iss. 4
Open Access | Times Cited: 1
Beyond TKIs: Advancing Therapeutic Frontiers with Immunotherapy, Targeted Agents, and Combination Strategies in Resistant Chronic Myeloid Leukemia
Imran Rashid Rangraze, Mohamed El‐Tanani, Adil Farooq Wali, et al.
Hemato (2025) Vol. 6, Iss. 1, pp. 6-6
Open Access
Imran Rashid Rangraze, Mohamed El‐Tanani, Adil Farooq Wali, et al.
Hemato (2025) Vol. 6, Iss. 1, pp. 6-6
Open Access
Impact of Tyrosine Kinase Inhibitors on the Expression Pattern of Epigenetic Regulators
Kinga Tóth, Zsuzsanna Gaál
Cancers (2025) Vol. 17, Iss. 8, pp. 1282-1282
Open Access
Kinga Tóth, Zsuzsanna Gaál
Cancers (2025) Vol. 17, Iss. 8, pp. 1282-1282
Open Access
Promotion of Autophagy and Apoptosis in Colorectal Cancer Exposed to Imatinib and Thymoquinone
Dalia El‐Khouly, Nadia A. Thabet, Mohamed M. Sayed‐Ahmed, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 4
Open Access
Dalia El‐Khouly, Nadia A. Thabet, Mohamed M. Sayed‐Ahmed, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 4
Open Access
Allele-Specific PCR for Detection of Missense Mutations in the Chimeric BCR::ABL1 Gene Causing Failure of Tyrosine Kinase Inhibitor Therapy in CML Patients
Anastasia Skripkina, Irina Fevraleva, Elena Kuzmina, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3728-3728
Open Access
Anastasia Skripkina, Irina Fevraleva, Elena Kuzmina, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3728-3728
Open Access
Myeloid-derived suppressor cells: Implication in myeloid malignancies and immunotherapy
Sunčica Kapor, Milica Radojković, Juan F. Santibáñez
Acta Histochemica (2024) Vol. 126, Iss. 5-7, pp. 152183-152183
Closed Access | Times Cited: 2
Sunčica Kapor, Milica Radojković, Juan F. Santibáñez
Acta Histochemica (2024) Vol. 126, Iss. 5-7, pp. 152183-152183
Closed Access | Times Cited: 2
Lycorine attenuated proliferation and induced apoptosis on imatinib-resistant K562 cell by inhibiting autophagy
Jun Bai, Zuxi Feng, Yaqiong Chen, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Jun Bai, Zuxi Feng, Yaqiong Chen, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Febuxostat enhances the efficacy of dasatinib by inhibiting ATP-binding cassette subfamily G member 2 (ABCG2) in chronic myeloid leukemia cells
Kai Kawashima, Kenji Ikemura, Miho Takemura, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117709-117709
Open Access | Times Cited: 1
Kai Kawashima, Kenji Ikemura, Miho Takemura, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 181, pp. 117709-117709
Open Access | Times Cited: 1
Investigations on druggable gene mutations related to AML/ALL lineage genes in Advanced Phases of CML: Implications in patient-tailored therapy of blast crisis CML in TKI era
Nawaf Alanazi, Abdulkareem Al-Garni, Sarah AlMukhaylid, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Nawaf Alanazi, Abdulkareem Al-Garni, Sarah AlMukhaylid, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
An Overview of Myeloid Blast-Phase Chronic Myeloid Leukemia
Gulsum E. Pamuk, Lori A. Ehrlich
Cancers (2024) Vol. 16, Iss. 21, pp. 3615-3615
Open Access
Gulsum E. Pamuk, Lori A. Ehrlich
Cancers (2024) Vol. 16, Iss. 21, pp. 3615-3615
Open Access
Application and Progress of Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia
慧娟 王
Advances in Clinical Medicine (2024) Vol. 14, Iss. 10, pp. 1513-1520
Closed Access
慧娟 王
Advances in Clinical Medicine (2024) Vol. 14, Iss. 10, pp. 1513-1520
Closed Access
Understanding and overcoming resistance to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML)
Alessandro Laganà, Emilia Scalzulli, Maria Laura Bisegna, et al.
Expert Review of Hematology (2024)
Closed Access
Alessandro Laganà, Emilia Scalzulli, Maria Laura Bisegna, et al.
Expert Review of Hematology (2024)
Closed Access
